# Janux Therapeutics, Inc.: Form 8-K, filed Nov 6, 2025

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: 8-K
- Filed: 2025-11-06
- Accepted by EDGAR: Nov 6, 2025, 16:10 ET
- Period: 2025-11-06
- Accession: 0001193125-25-269518
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000119312525269518/janx-20251106.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000119312525269518/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000119312525269518/janx-20251106.htm

Filed Nov 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-269518. Last ingested by Listed: Nov 15, 2026, 00:55 ET. No prices; not investment advice.
